A-007

DRUG2 trials

Sponsors

DEKK-TEC, Inc., Tigris Pharmaceuticals

Conditions

Cervical Intraepithelial NeoplasiaHIV InfectionsLymphoproliferative DisordersSarcoma, KaposiUterine Cervical Dysplasia

Phase 1

Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders

CompletedNCT00002153

DEKK-TEC, Inc.HIV Infections, Lymphoproliferative Disorders, Sarcoma, Kaposi

Target: 25Updated: 2005-06-24

Phase 2

A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)

CompletedNCT00596258

Tigris PharmaceuticalsCervical Intraepithelial Neoplasia, Uterine Cervical Dysplasia

Start: 2007-11-30End: 2008-08-31Updated: 2009-05-22